1. Home
  2. CTMX vs INTT Comparison

CTMX vs INTT Comparison

Compare CTMX & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$4.16

Market Cap

596.2M

Sector

Health Care

ML Signal

HOLD

Logo inTest Corporation

INTT

inTest Corporation

HOLD

Current Price

$7.59

Market Cap

94.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTMX
INTT
Founded
2008
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
596.2M
94.9M
IPO Year
2015
1997

Fundamental Metrics

Financial Performance
Metric
CTMX
INTT
Price
$4.16
$7.59
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
2
Target Price
$6.50
$12.00
AVG Volume (30 Days)
2.1M
34.4K
Earning Date
11-06-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
50.22
N/A
EPS
0.24
N/A
Revenue
$113,631,000.00
$117,606,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$9.60
P/E Ratio
$17.49
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.40
$5.24
52 Week High
$4.62
$9.77

Technical Indicators

Market Signals
Indicator
CTMX
INTT
Relative Strength Index (RSI) 57.36 45.67
Support Level $3.78 $7.53
Resistance Level $4.20 $8.00
Average True Range (ATR) 0.24 0.47
MACD -0.02 0.01
Stochastic Oscillator 73.88 23.96

Price Performance

Historical Comparison
CTMX
INTT

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About INTT inTest Corporation

inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). The company operates their business and sells its products both domestically and internationally.

Share on Social Networks: